| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/13/1989 | US4839341 Stabilized insulin formulations |
| 06/13/1989 | US4839179 Preparation of a composition based on a finely divided active principle of low water solubility |
| 06/13/1989 | US4839177 System for the controlled-rate release of active substances |
| 06/13/1989 | US4839176 Therapeutic agents |
| 06/13/1989 | US4839175 Liposomes with enhanced retention on mucosal tissue |
| 06/13/1989 | US4839174 Novel transdermal nicotine patch |
| 06/13/1989 | US4839111 Preparation of solid core liposomes |
| 06/13/1989 | US4838862 Portable controlled release osmotic infusion device |
| 06/13/1989 | EP0305384A4 Water soluble polyvinyl lactam-drug complexes. |
| 06/13/1989 | CA1255597A1 Solid medicament formulations containing dihydropyridines and a process for their preparation |
| 06/13/1989 | CA1255592A1 Transdermal drug patches |
| 06/13/1989 | CA1255580A1 Method and article for treating periodontal disease |
| 06/13/1989 | CA1255563A1 Pseudoephedrine, brompheniramine therapy |
| 06/13/1989 | CA1255562A1 Colon delivery system |
| 06/08/1989 | DE3826481A1 Method and device for tensile force measurement on continuously moving material under test |
| 06/07/1989 | EP0319318A2 Method for double dipping gelatin coated caplets |
| 06/07/1989 | EP0319136A1 Novel liposomes and a process for their preparation |
| 06/07/1989 | EP0319126A2 Process for preparation of polyol fatty acid ester and glyceride mixture obtained |
| 06/07/1989 | EP0319074A1 Pharmaceutical composition and process for its preparation |
| 06/07/1989 | EP0318906A1 Lyophilized preparation of platinum compound |
| 06/07/1989 | EP0318522A1 Anti-inflammatory cream composition |
| 06/07/1989 | EP0318512A1 Delivery systems for pharmacological agents |
| 06/07/1989 | EP0318492A1 Pharmaceutical formulations comprising microcapsules |
| 06/06/1989 | US4837381 Compositions for parenteral administration and their use |
| 06/06/1989 | US4837380 Liposome-calcitonin preparation |
| 06/06/1989 | US4837378 Topical metronidazole formulations and therapeutic uses thereof |
| 06/06/1989 | US4837285 Collagen matrix beads for soft tissue repair |
| 06/06/1989 | US4837255 Palatable hypocholesterolaemic gel formulation containing a pharmaceutically acceptable non-digestible anion exchange resin |
| 06/06/1989 | US4837214 Suppository and base thereof |
| 06/06/1989 | US4837213 Pharmaceutical vehicle for active substances in the form of an anhydrous gel |
| 06/06/1989 | US4837208 Treatment of human viral infections |
| 06/06/1989 | US4837203 Peptide antiasthmatic agents |
| 06/06/1989 | US4837111 Dosage form for dispensing drug for human therapy |
| 06/06/1989 | US4837033 Method for the preparation of a coated solid medicament |
| 06/06/1989 | US4837032 Theophylline sustained release tablet |
| 06/06/1989 | US4837031 Compositions containing ibuprofen |
| 06/06/1989 | US4837030 Novel controlled release formulations of tetracycline compounds |
| 06/06/1989 | US4837029 Dimethyl polysiloxane, cationic or nonionic surfactant |
| 06/06/1989 | US4837028 Larger size; containing spingomyelin or phosphatide and ganglioside |
| 06/06/1989 | US4837027 Therapeutic agent stored as salt, moisture activates |
| 06/06/1989 | US4837026 Transdermal and systemic preparation and method |
| 06/06/1989 | US4837025 Self-adhesive device for the percutaneous administration of an active ingredient |
| 06/06/1989 | US4837004 Rumen-stable pellets |
| 06/06/1989 | US4836928 Separation method, separation device and separation apparatus for separating body fluid into respective components |
| 06/06/1989 | CA1255271A1 Apparatus and method for sealing capsules |
| 06/06/1989 | CA1255229A1 Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine |
| 06/06/1989 | CA1255227A1 Method for production of stable nicorandil preparation |
| 06/06/1989 | CA1255225A1 Long-lasting adhesive antifungal suppositories |
| 06/06/1989 | CA1255223A1 Pellet formulation |
| 06/06/1989 | CA1255222A1 Pharmaceutical composition |
| 06/06/1989 | CA1255175A1 Self-adhesive plaster |
| 06/01/1989 | WO1989004858A1 Supercritical fluid reverse micelle separation |
| 06/01/1989 | WO1989004844A1 Processes for microemulsion polymerization employing novel microemulsion systems |
| 06/01/1989 | WO1989004842A1 Microporous granular starch matrix composition |
| 06/01/1989 | WO1989004761A1 A process for coating a tablet composition |
| 06/01/1989 | WO1989004714A1 Process for microencapsulation of low-melting solid substances |
| 06/01/1989 | WO1989004689A1 Glassy matrix for administration of beneficial agent |
| 06/01/1989 | WO1989004687A1 Microcrystalline matrix for administration of beneficial agent |
| 06/01/1989 | WO1989004673A1 Method for preparing a solid sustained release form of a functionally active composition and the dosage form so obtained |
| 06/01/1989 | WO1989004658A1 Onset-hastened/enhanced analgesia using s(+) ketoprofen |
| 06/01/1989 | WO1989004657A1 Sustained release of encapsulated molecules |
| 06/01/1989 | WO1989004656A1 Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes |
| 06/01/1989 | WO1989004655A1 In vivo delivery of neurotransmitters by implanted, encapsulated cells |
| 06/01/1989 | WO1989004654A1 Controlled administration of beneficial agent to blood |
| 06/01/1989 | WO1989004651A1 Composition based on hydrated lipid lamellar phases or liposomes containing tyrosine or a tyrosine derivative and cosmetic or pharmaceutical composition, in particular dermatological composition, with pigmenting activity, containing it |
| 06/01/1989 | WO1989004648A1 Temperature-controlled active agent dispenser |
| 06/01/1989 | DE3837669A1 Die verwendung koerpereigener fibroblasten und epidermiszellen als wirkstoff-traeger fuer die intrakorporale behandlung und als wirkstoffvermittler fuer die lokalbehandlung The use koerpereigener fibroblasts and epidermal cells as drug carriers for intracorporeal treatment and drug as intermediaries for the local treatment |
| 05/31/1989 | EP0318398A1 Diltiazem sustained release form and medicament thereof |
| 05/31/1989 | EP0318385A1 Therapeutic transdermal device and its process of preparation |
| 05/31/1989 | EP0318369A1 Hydrated lipidic lamellar composition or liposome containing tyrosine or tyrosine derivative and cosmetic or pharmaceutical topical tanning composition thereof |
| 05/31/1989 | EP0318314A1 A process for coating a tablet composition |
| 05/31/1989 | EP0318246A2 Process and means to avoid absorption of harmful compounds |
| 05/31/1989 | EP0318211A1 Nedocromil sodium compositions and methods for their preparation |
| 05/31/1989 | EP0318146A1 Antibiotic solutions and the lyophilization thereof |
| 05/31/1989 | EP0317878A1 Stabilized pharmaceutical agents, process for preparing them, and stable pharmaceutical preparations |
| 05/31/1989 | EP0317803A1 Preparation of sized populations of liposomes |
| 05/31/1989 | EP0317780A1 Sustained (controlled) release delivery system for substituted dihydropyridine calcium channel blockers |
| 05/30/1989 | US4835248 Biologically degradable polyamide for depot preparations having controlled release of the active compound |
| 05/30/1989 | US4835188 Spray dried ibuprofen |
| 05/30/1989 | US4835187 Spray dried ibuprofen |
| 05/30/1989 | US4835186 Silica, cellulose acetate phthalate, alkanol |
| 05/30/1989 | US4835142 Powdery pharmaceutical composition suitable for application to mucosa of oral or nasal cavity |
| 05/30/1989 | US4835139 Process for increasing the antagonistic effect of peptidic compounds on hormone-dependent diseases |
| 05/30/1989 | US4835138 Choline esters as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal cavities |
| 05/30/1989 | US4834985 Solid matric of water soluble polydextrose, cyclodextrin or cellulose ether and fatty alcohol or polyoxyalkylene glycol |
| 05/30/1989 | US4834984 Controlled release dihydrocodeine composition |
| 05/30/1989 | US4834982 Potassium-neutral salureticum with anti-hypertensive effect |
| 05/30/1989 | US4834981 Dietary vaccine for inhibiting metabolism of methanol |
| 05/30/1989 | US4834980 Transdermal delivery of azatidine |
| 05/30/1989 | US4834979 Medical bandage for administering beneficial drug |
| 05/30/1989 | US4834978 Method of transdermal drug delivery |
| 05/30/1989 | US4834969 Nonionic poly(hydroxypropylether) surfactant; partially halogenated hydrocarbon propellant |
| 05/30/1989 | US4834966 Pharmaceutical composition with analgesic activity |
| 05/30/1989 | US4834965 Controlled release pharmaceutical composition |
| 05/30/1989 | US4834898 Surfactants |
| 05/30/1989 | CA1254835A1 Dentifrice formulation and method of treating teeth, mouth and throat therewith to reduce plaque accumulation and irritation |
| 05/30/1989 | CA1254832A1 Interferon administration vehicles |
| 05/30/1989 | CA1254808A1 Pharmaceutical dosage unit |
| 05/24/1989 | EP0317510A2 Capsule and its method of manufacturing |
| 05/24/1989 | EP0317405A1 Ophthalmic solution comprising iodine-polyvinylpyrrolidone complex |